[Editorial] Asthma—hope for the future?
334 million people worldwide are affected by asthma. Despite falling mortality rates, the global health burden of asthma persists, and there is still no cure. In the Lancet Series on asthma, Richard Beasley and colleagues discuss the risk factors for asthma development and consider the case for disease prevention. Kian Fan Chung reviews evidence for treatment targeting the interleukin pathway.